DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma

Lian Zhang, Hongtao Li, Rachel Shereda, Qianjin Lu, Daniel J. Weisenberger, Casey L. O’Connell, Keigo Machida, Woojin An, Heinz‐Josef Lenz, Anthony B. El-Khoueiry, Peter A. Jones, Minmin Liu, Gangning Liang